MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Signaling through the adaptor protein myeloid differentiation factor 88 (MyD88) promotes carcinogenesis in several cancer models. In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC). The inability of Myd88(-/-) mice to heal ulcers generated upon injury creates an altered inflammatory environment that induces early alterations in expression of genes encoding proinflammatory factors, as well as pathways regulating cell proliferation, apoptosis, and DNA repair, resulting in a dramatic increase in adenoma formation and progression to infiltrating adenocarcinomas with frequent clonal mutations in the beta-catenin gene. Others have reported that toll-like receptor (Tlr) 4-deficient mice have a similar susceptibility to colitis to Myd88-deficient mice but, unlike the latter, are resistant to CAC. We have observed that mice deficient for Tlr2 or Il1r do not show a differential susceptibility to colitis or CAC. However, upon AOM/DSS treatment Il18(-/-) and Il18r1(-/-) mice were more susceptible to colitis and polyp formation than wild-type mice, suggesting that the phenotype of Myd88(-/-) mice is, in part, a result of their inability to signal through the IL-18 receptor. This study revealed a previously unknown level of complexity surrounding MyD88 activities downstream of different receptors that impact tissue homeostasis and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 4×
“We observed enhanced expression of several known STAT3-dependent genes (Yu et al., 2009) in addition to Il6 and Il11 in AOM/DSS-treated Myd88/ mice, including Cox2, Hif1a, and several metalloproteases.”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“RESULTS Myd88/ mice show increased susceptibility to develop colonic tumors after AOM/DSS administration Myd88/ mice are highly susceptible to the development of colitis induced by irradiation or DSS as a result of reduced ability to repair the mucosal integrity after injury with significant morbidity and mortalit…”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · cited 2×
“STAT3 activation in both epithelial cells and in stromal and infiltrating cells has been shown to regulate the tumor inflammatory environment as well as to have direct effects on the tumor itself by inducing antiapoptotic, proangiogenic, and proproliferative gene expression programs (Grivennikov et al., 2009; Yu et al…”
BackgroundSystematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617 · cited 2×
“…and Il18/ mice to colon carcinogenesis might exclusively be the result of the lack of an immunosurveillance effect of adaptive immunity and IFN- (Dunn et al., 2006), particularly when it is considered that Rag/ immunodeficient mice have reduced rather than increased susceptibility to colon…”
BackgroundStabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Cited by
Items 401–451 of 451
Inflammasomes in Inflammatory Bowel Disease
Strowig, T., & Flavell, R. A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0998-4_7
Implication de l'interleukine-18 dans la cytotoxicité anti-tumorale des polynucléaires éosinophiles
Gatault, S. (2015) · theses.fr (ABES) · doi:10.70675/0e9d820bz6f4dz4f96z9742za1ecd1e4a17f
Rodríguez‐Nogales, A. (2016) · Institutional Repository of the University of Granada (University of Granada)
Aspects of Autophagy in Inflammatory Bowel Disease
Sípos, F., & Műzes, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-30079-5_12
Fonction et mode d'action du gène homéotique intestinal Cdx2 dans les cancers de l'intestin
Balbinot, C. (2017) · theses.fr (ABES) · doi:10.70675/14dfeeacz673fz40b9zb0b9z86792101133e
Inflammatory Biomarkers for Cancer
Corthay, A., & Haraldsen, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_10 · Cited by 1
Exploration of immunogene in colon cancer recurrence
Sun, Q.-R., Chen, Y., Yuan, S., & Liao, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24218
Inflammasome regulation and activation in the intestinal epithelium
Lei, A. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-mzngoy5ob
Organ Microbiota in Cancer Development: The Holy Grail of Biological Carcinogenesis
Kutikhin, A. G., Yuzhalin, A. E., & Брусина, Е. Б. (2012) · Springer eBooks · doi:10.1007/978-94-007-5955-8_6
Krieg, C., Weber, L. M., Fosso, B., Hardiman, G., Mileti, E., Aidy, S. E., Marzano, M., Robinson, M. D., & Guglietta, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.18.426963
“In support of this observation, deficiencies in innate sensing mechanisms have been associated with increased intestinal inflammation and CRC in human and mouse models (Coleman et al., 2018; de Souza et al., 2018; Garrett et al., 2007; Rakoff-Nahoum and Medzhitov, 2007; Salcedo et al., 2010).”
BackgroundIrrazábal, T. (2018) · TSpace (University of Toronto)
Fernandes, F. P. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-01072021-115731
Innate Sensing by Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal TumorigenesisPreprint
Koliaraki, V., Chalkidi, N., Henriques, A. R., Tzaferis, C., Polykratis, A., Waisman, A., Müller, W., Hackam, D. J., Pasparakis, M., & Kollias, G. A. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3249781
Anti-cancer Immunologic Function of Recombinant Interleukin-18
Saetang, J. (2018) · PSU Knowledge Bank (Prince of Songkla University)
Immunology and immunotherapy in CRC
Cordero, O. J., Varela‐Calviño, R., Graña-Suárez, B., & García-López, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90055-3.00031-4
Immunology and Immunotherapy of Colorectal Cancer
Cordero, O. J., Varela‐Calviño, R., & Graña-Suárez, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-57949-4_10
Inflammatory Biomarkers for Cancer
Corthay, A., & Haraldsen, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_12
Tartey, S., Neale, G. A. M., Vogel, P., Malireddi, R. K. S., & Kanneganti, T. (2023) · doi:10.1158/0008-5472.c.6513139.v1
Davis, M. B., Vasquez-Dunddel, D., Fu, J., Albesiano, E., Pardoll, D. M., & Kim, Y. J. (2023) · doi:10.1158/1078-0432.c.6518340.v1
Consequences of SARS-CoV-2 COVID-19 on the Health of Women and Men Ayacucho- Peru
Luisa, A. C. (2022) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2022.23.556124
Systemic Oncosphere: Host Innate Immune System
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_19
Three Pharmacological Models: Inducing Inflammatory Bowel Disease and Colitis-Associated Cancer
Sha Zeng, A. (2023) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2023.19.556025
Rôle de l'immunomodulateur P2RX7 dans le cancer et la fibrose pulmonaire
Hreich, S. J. D. (2022) · theses.fr (ABES) · doi:10.70675/4b399e7fzb436z4e8fz8045z90c0862c799d
Epithelial Barrier Dysfunction in Disease
Pardo-Pastor, C., López-Posadas, R., & Zapater, E. O. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4669-7
Guilloteau, E. (2022) · theses.fr (ABES) · doi:10.70675/3b553e89z0a3dz4302z871fzbcb70c29ac8a
Ramírez-Pérez, S., Vekariya, R., Gautam, S., Reyes‐Pérez, I. V., Drissi, H., & Bhattaram, P. (2023) · Figshare · doi:10.6084/m9.figshare.24196738
Ramírez-Pérez, S., Vekariya, R., Gautam, S., Reyes‐Pérez, I. V., Drissi, H., & Bhattaram, P. (2023) · Figshare · doi:10.6084/m9.figshare.24196741
GUT MICROBIOME IN CANCER: THE NEXT BIG OPPORTUNITY FOR BETTER PATIENT OUTCOMES?
Povšin, J., Sotošek, T., Novak, M., & Breznik, B. (2025) · Slovenian Veterinary Research · doi:10.26873/svr-2029-2024
“Butyrate activates the GPR109A receptor, which then induces IL-18 production in epithelial cells of the intestinal mucosa, which may trigger the repair mechanisms of the mucous layer (52).”
Hsu, C., Jasim, S. A., Rasool, K. H., Malathi, H., Kaur, J., Jabir, M. S., Alhajlah, S., Kumar, A., Jawad, S. F., & Husseen, B. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152344
Liu, C., Zhao, M., Wang, X., Wang, S., & Wang, X. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157007
Pedrosa, L. D. F. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.112.2025.tde-30092025-152132
Function of Peripheral Blood Eosinophils in Melanoma
Wendlinger, S. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-30119
Ramírez-Pérez, S., Vekariya, R., Gautam, S., Reyes‐Pérez, I. V., Drissi, H., & Bhattaram, P. (2023) · Figshare · doi:10.6084/m9.figshare.24196732
PKN2 regulates cell-junctions to limit colitisPreprint
Henry, J. C., Campbell, A., Huddar, P., Sewell, J., Menezes, S., Passman, A. M., Smith, K., McGauran, S., Quétier, I., Lin, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.15.694339
Andrusiów, S., Dratwa, M., Łacina, P., Bochen, P., Gładysz, K., Szponar, B., Koszewicz, M. A., & Bogunia‐Kubik, K. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1738817
“Despite numerous studies, the role that IL-18 plays in autoimmune processes remains unclear, and research findings often remain contradictory (Nowarski et al., 2015; Salcedo et al., 2010; Elinav et al., 2011).”
Inflammasomes : des mécanismes d’activation de la caspase-1 à la progression tumorale
Guey, B. (2016) · theses.fr (ABES) · doi:10.70675/42ebd7a3zcde2z449czb32cz9db33732e38c · Cited by 2
Régulation des cellules NK par le TGF-β
Viel, S. (2016) · theses.fr (ABES) · doi:10.70675/d36349aezc6afz4166z8968z40abbe3c36c2 · Cited by 1
L’interleukine-33 : de son expression dans le cancer du sein à l’activation des cellules NK
Blanc, E. (2017) · theses.fr (ABES) · doi:10.70675/00d5a147z4225z472fzaa46za6441b64b3bf
Benoit-Lizon, I. (2021) · theses.fr (ABES) · doi:10.70675/2b159c6dz31eez488ez8948z2fc5261a35dc
Zhang, J., Bao, L., Li, X., Li, J., 崔珈衔, Qiao, L., He, X., Zhang, M., Lu, J., Zhang, X., et al. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5834
Andrusiów, S., Brzoza, A., Łacina, P., Dratwa-Kuźmin, M., Raczkowska, J., Kujawa, D., Romańczuk, K., Gancarek, M., Bochen, P., Dziadkowiak, E., et al. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1802462
“Despite extensive research, the exact role of IL-18 in autoimmune disorders remains unclear, with many findings proving contradictory (Elinav et al., 2011; Nowarski et al., 2015; Salcedo et al., 2010).”
Sarkar, P., Shannigrahi, S., Sen, O., Adak, S., Jana, P., & Manna, S. (2026) · ChemistrySelect · doi:10.1002/slct.202507043
Lin, J., Lin, H., Zhang, Z., & Wang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892843
Couturier-Maillard, A. (2012) · theses.fr (ABES) · doi:10.70675/0b7820f4zd2a8z4cf0zb124z58d7f3c15224 · Cited by 1
Metadata
- Authors
- Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., Marincola, F. M., & Trinchieri, G.
- Affiliations
- National Cancer Institute (US)
- National Institutes of Health (US)
- Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701 1
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Trinchieri, Giorgio
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-07-12
- Volume
- 207
- Issue
- 8
- Pages
- 1625-1636
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2916129
- OpenAlex
- W2118983602
- Cited by
- 429
- References
- 44
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 24 · 2022: 21 · 2021: 24 · 2020: 26 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 18 · 2015: 35 · 2014: 36 · 2013: 42 · 2012: 37
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HHSN261200800001C)
- National Cancer Institute (HHSN261200800001E))
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- MyD88 signaling, IL-18, interleukin-18 receptor, colitis-associated colorectal cancer, colon adenocarcinoma, carcinogenesis, inflammatory bowel disease, CTNNB1 mutation, adenoma formation, MyD88-deficient mice, TLR2, TLR4, tissue homeostasis
- MeSH terms
- Adenocarcinoma, Animals, Azoxymethane, Colon, Colonic Neoplasms, Colonic Polyps, Epithelial Cells, Intestinal Mucosa, Mice, Inbred C57BL, Mutation, Phosphorylation, Specific Pathogen-Free Organisms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression, Dextran Sulfate, Apoptosis, Mice, Knockout, Genetic Predisposition to Disease, Interleukin-18, Gene Expression Profiling, DNA Repair Enzymes, Cell Proliferation, STAT3 Transcription Factor, beta Catenin, Mice, Cyclooxygenase 2, Receptors, Interleukin-1 Type I, Myeloid Differentiation Factor 88, Interleukin-18 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.